glp-1 receptor agonists should be avoided in patients with MYTH BUSTER #1 “Weight-loss injections like medicines are not safe.” Is this really true? GLP-1 (such as Ozempic®) are among the most discussed anti-obesity medicines today. Unfortunately, misinformation on GLP-1 receptor agonists are transforming
Description
The Byetta exenatide, it opened up a whole new market, says toxicologist Takacs
The FDA, ADA, and AACE do not support the use of this combination in patients with type 2 diabetes
Stopping abruptly can lead to weight regain
Br J Anaesth 126(3):567571
In November, it seemed like the two might rekindle their old flame
doi: 10.1177/10600280211055804 [DOI] [PubMed] [Google Scholar] 181.Sen S, Potnuru PP, Hernandez N, et al
